| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.26 | 7e-08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |